Goldman Sachs’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-72,000
Closed -$184K 6684
2021
Q1
$184K Buy
+72,000
New +$295K ﹤0.01% 5677
2018
Q4
Sell
-180,000
Closed -$495K 5805
2018
Q3
$495K Buy
+180,000
New +$578K ﹤0.01% 4429
2017
Q2
Sell
-37,500
Closed -$459K 7051
2017
Q1
$459K Sell
37,500
-37,500
-50% -$546K ﹤0.01% 5110
2016
Q4
$1.19M Sell
75,000
-75,000
-50% -$1.26M ﹤0.01% 4294
2016
Q3
$2.73M Buy
+150,000
New +$2.45M ﹤0.01% 3557

Other funds holding OTIC

Goldman Sachs's OTIC Position: Q3 2021 in Review

Goldman Sachs sold out of Otonomy, Inc. (OTIC) in Q3 2021, closing a stake of 14,145 shares — an estimated $32K sold.

Goldman Sachs first reported a position in OTIC in Q3 2014 and held it in 27 quarters. The position peaked at $14.9M in Q1 2015. 55 funds tracked by Wall St. Rank hold OTIC as of Q3 2021.

  • Goldman Sachs reported no remaining Otonomy, Inc. position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 14,145 Otonomy, Inc. shares in Q3 2021, an estimated $32K.
  • Goldman Sachs first reported a position in Otonomy, Inc. in Q3 2014 and held it in 27 quarters.
  • Goldman Sachs's Otonomy, Inc. position peaked at $14.9M in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.